Toxic hydrolysis product from a biodegradable foam implant.
about
A physiologically based pharmacokinetic model for 2,4-toluenediamine leached from polyurethane foam-covered breast implantsA novel bioactive osteogenesis scaffold delivers ascorbic acid, β-glycerophosphate, and dexamethasone in vivo to promote bone regeneration.Current implant surface technology: an examination of their nanostructure and their influence on fibroblast alignment and biocompatibility.Breast implants: the good, the bad and the ugly. Can nanotechnology improve implants?Design and development of reactive injectable and settable polymeric biomaterials.Breast Implant-Associated Anaplastic Large Cell Lymphoma: Report of 2 Cases and Review of the Literature.Back to the future: a 15-year experience with polyurethane foam-covered breast implants using the partial-subfascial technique.High Modulus Biodegradable Polyurethanes for Vascular Stents: Evaluation of Accelerated in vitro Degradation and Cell Viability of Degradation ProductsDo implanted medical devices cause cancer?The evolution of FDA policy on silicone breast implants: a case study of politics, bureaucracy, and business in the process of decision-making.Development of an animal model for testing human breast implantation materials.Breast implants.Antiadhesive effect of polyurethane foam packing in the guinea pig middle ear.Shape memory polyurethanes with oxidation-induced degradation: In vivo and in vitro correlations for endovascular material applications.Effects of hydrolysis on a new biodegradable co-polymer.Thermoresponsive Random Poly(ether urethanes) with Tailorable LCSTs for Anticancer Drug Delivery
P2860
Q24682579-1E9C52E3-1056-495C-97FC-25BB570E683BQ33761842-6962E151-3916-451D-8FAB-26B3D6DC6BC2Q37233226-4E695B0F-5F46-4657-81D9-CC56DA30A694Q37941475-052F7E02-04B5-4A60-AC76-A9EBEB8541F9Q38105523-C3A583F6-4545-4FF3-9E9A-C1B19A5E3A57Q38221032-7D402A01-098D-421E-AC54-9F5116317C8BQ39674520-8CB544B7-FB7E-4181-BF83-447E79B71F6BQ40349126-8D386B92-C8F0-4A85-A4B6-BC0FCB083544Q40691517-5E26D001-0159-438B-9C68-687A4408CAD1Q40954506-6508277F-6352-4F3A-9518-B3EC99963594Q41097495-6D429823-7A60-419A-AB81-16385E5E0A89Q42387095-15C33238-726D-4130-A912-C9830E60AE22Q46919900-A263E00F-8E41-4893-9235-7EA1B1BA08BEQ47989164-EB0141B8-28EB-45FD-98F1-3E9BA68A1870Q51150383-6CCBCEC9-9256-497B-A8C8-05D9A9E51E27Q57343473-FCCD0390-59FE-4C4F-98C5-84AC82CAC867
P2860
Toxic hydrolysis product from a biodegradable foam implant.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
Toxic hydrolysis product from a biodegradable foam implant.
@en
type
label
Toxic hydrolysis product from a biodegradable foam implant.
@en
prefLabel
Toxic hydrolysis product from a biodegradable foam implant.
@en
P2093
P356
P1476
Toxic hydrolysis product from a biodegradable foam implant.
@en
P2093
P304
P356
10.1002/JBM.820231406
P433
P577
1989-12-01T00:00:00Z